DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Manns M, Samuel D, Gane EJ. et al.
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
The Lancet Infectious diseases 2016;
16: 685-697
We do not assume any responsibility for the contents of the web pages of other providers.